Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,553,454
-$32,563,930 QoQ
Shares Held
544,021
-86.8% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 323 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 0%
Shared 89%
None 11%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. ADMA ranks #85 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ADMA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,553,454 | 544,021 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $37,117,384 | 4,119,577 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $214,962,078 | 11,785,202 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $183,330,300 | 12,505,478 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $233,418,342 | 12,818,141 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $255,279,370 | 12,866,904 | Shares | Defined | 2025-05-12 | |
| 2025-03-31 | $255,279,375 | 12,866,904 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $193,730,767 | 11,296,255 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $252,269,178 | 12,619,769 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $147,248,825 | 13,170,736 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $51,507,897 | 7,804,227 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $27,625,211 | 6,111,773 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $19,393,452 | 5,417,166 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $18,415,755 | 4,990,720 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,976,097 | 4,826,616 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $16,340,521 | 4,211,475 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,324,569 | 3,425,749 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $625,388 | 315,853 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $785,917 | 429,463 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $789,495 | 559,926 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $31,496 | 17,896 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $27,873 | 14,294 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||